Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
275 studies found for:    "Tylosis"
Show Display Options
Rank Status Study
1 Completed
Has Results
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Condition: Keratosis
Intervention: Drug: imiquimod cream
2 Active, not recruiting Treatment of Actinic Keratoses (AK) on the Face
Condition: Actinic Keratoses
Interventions: Drug: ingenol mebutate 0.015%;   Other: dermasil lotion
3 Recruiting Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses
Condition: Actinic Keratosis
Interventions: Drug: GDC 695;   Drug: Diclofenac Sodium Gel, 3%;   Drug: Vehicle gel
4 Completed
Has Results
The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses
Condition: Actinic Keratoses
Interventions: Drug: Oleogel-S10 100 mg/g;   Drug: Placebo (petroleum jelly)
5 Unknown  Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
Condition: Actinic Keratosis
Intervention: Drug: Ingenol Mebutate
6 Completed Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + ALA Photodynamic Therapy
Condition: Actinic Keratosis
Interventions: Drug: Aminolevulinic Acid;   Drug: Topical Solution Vehicle;   Device: BLU-U;   Procedure: Cryotherapy
7 Completed
Has Results
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities
Condition: Actinic Keratosis
Interventions: Drug: Aminolevulinic Acid (ALA);   Drug: Topical Solution Vehicle;   Device: Blue Light Photodynamic Therapy Illuminator (BLU-U)
8 Completed
Has Results
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
Condition: Keratosis, Actinic
Interventions: Drug: Aminolevulinic Acid PDT (ALA);   Drug: Vehicle PDT (VEH)
9 Completed Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients
Condition: Actinic Keratosis
Interventions: Drug: Investigational Treatment;   Drug: Active comparator
10 Recruiting Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%
Condition: Actinic Keratosis
Intervention: Drug: Inggenol Mebutate 0.015%
11 Recruiting Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Vehicle gel;   Drug: SR-T100 with 2.3% of SM
12 Completed
Has Results
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
Condition: Actinic Keratosis
Interventions: Drug: imiquimod cream;   Drug: placebo cream
13 Completed
Has Results
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
Condition: Actinic Keratoses
Intervention:
14 Completed
Has Results
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
Condition: Actinic Keratoses
Interventions: Drug: imiquimod cream;   Drug: Placebo
15 Completed
Has Results
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
Condition: Actinic Keratosis
Interventions: Drug: Imiquimod cream;   Drug: Placebo cream
16 Unknown  Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Device: Eryfotona AK-NMSC® cream;   Other: Sunscreen SPF 50+
17 Unknown  Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic Keratoses
Condition: Actinic Keratosis
Interventions: Procedure: ablative CO2 laser therapy;   Procedure: photodynamic therapy
18 Unknown  Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Imiquimod cream 3.75%;   Drug: Placebo cream
19 Completed Evaluation of Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions
Condition: Actinic Keratosis
Interventions: Drug: Aldara (Imiquimod);   Other: Vehicle cream
20 Completed Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions
Condition: Actinic Keratosis
Interventions: Drug: Resiquimod 0.03%;   Drug: Resiquimod 0.01%;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.